Literature DB >> 11589743

Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: consequences for the regulation of hair growth.

F Jarrousse1, S Boisnic, M C Branchet, J Y Beranger, G Godeau, L Breton, B A Bernard, Y F Mahé.   

Abstract

BACKGROUND: The control of human hair follicle growth and differentiation is dependent upon several well-identified factors, including androgens, cytokines, and growth factors. In humans, alopecia androgenetica is a common aging process thought to be regulated through complex genetic imbalances, which also involve several of these crucial identified factors (and probably others not yet characterized), alone or in combination. Among these factors, epidermal growth factor (EGF), as well as pro-inflammatory cytokines, play a pivotal role, as evidenced by their direct inhibitory effects on hair growth both in vitro and in vivo. Following such treatments, the in vitro growth of hair follicles was rapidly arrested and deleterious modifications of hair morphology were also observed. AIM: Because these cytokines act, at least partly, through the induction of matrix metalloproteinases (MMP), and because tissue remodeling occurs during the hair cycle, we attempted to identify and localize MMP in the human pilosebaceous unit.
METHOD: We used zymography to observe human hair follicles in culture in vitro.
RESULTS: We observed that human hair follicles in culture in vitro mainly and almost exclusively produce MMP-2 and MMP-9 gelatinolytic activities. Furthermore, after stimulation with EGF, tumor necrosis factor-alpha (TNF-alpha), or interleukin-1alpha (IL-1alpha), MMP-9 production was strongly increased. Using immunohistochemistry, we then precisely localized MMP-9 in the lower part of the inner root sheath (Henle's layer) of control human anagen hair follicles.
CONCLUSIONS: Cytokine- and EGF-induced upregulation of MMP-9 in the lower epithelial compartment of the human hair bulb is a major mechanism through which hair follicle involution, observed in alopecia, may occur.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589743     DOI: 10.1046/j.1365-4362.2001.01239.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Matriptase expression and zymogen activation in human pilosebaceous unit.

Authors:  Bai-Yao Wu; Shiao-Pieng Lee; Hui-Chung Hsiao; Han Chiu; Chi-Yung Chen; Yee Hui Yeo; Herng-Sheng Lee; Ya-Wen Chen; Malvika Kaul; Hiroaki Kataoka; Michael D Johnson; Jehng-Kang Wang; Chen-Yong Lin
Journal:  J Histochem Cytochem       Date:  2013-09-04       Impact factor: 2.479

2.  Matrix metalloproteinase-9 is involved in the regulation of hair canal formation.

Authors:  Andrey A Sharov; Mandy Schroeder; Tatyana Y Sharova; Andrei N Mardaryev; Eva M J Peters; Desmond J Tobin; Vladimir A Botchkarev
Journal:  J Invest Dermatol       Date:  2010-09-30       Impact factor: 8.551

3.  From buds to follicles: matrix metalloproteinases in developmental tissue remodeling during feather morphogenesis.

Authors:  Ting-Xin Jiang; Tai Lan Tuan; Ping Wu; Randall B Widelitz; Cheng-Ming Chuong
Journal:  Differentiation       Date:  2011-04-17       Impact factor: 3.533

4.  Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity.

Authors:  Yann F Mahe; Ahsène Cheniti; Charlotte Tacheau; Rosaria Antonelli; Lien Planard-Luong; Simon de Bernard; Laurent Buffat; Philippe Barbarat; Leila Kanoun-Copy
Journal:  Lasers Surg Med       Date:  2021-05-11

5.  Collagenase IV plays an important role in regulating hair cycle by inducing VEGF, IGF-1, and TGF-β expression.

Authors:  Chun Hou; Yong Miao; Jin Wang; Xue Wang; Chao-Yue Chen; Zhi-Qi Hu
Journal:  Drug Des Devel Ther       Date:  2015-09-25       Impact factor: 4.162

6.  Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle.

Authors:  Chun Hou; Yong Miao; Xue Wang; Chaoyue Chen; Bojie Lin; Zhiqi Hu
Journal:  Exp Ther Med       Date:  2016-05-09       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.